OncoTargets and Therapy (Oct 2020)

Acute Myeloid Leukemia with NUP98-RARG Gene Fusion Similar to Acute Promyelocytic Leukemia: Case Report and Literature Review

  • Tao S,
  • Song L,
  • Deng Y,
  • Chen Y,
  • Shi Y,
  • Gan Y,
  • Deng Z,
  • Ding B,
  • He Z,
  • Wang C,
  • Yu L

Journal volume & issue
Vol. Volume 13
pp. 10559 – 10566

Abstract

Read online

Shandong Tao,1,2,* Lixiao Song,1,2,* Yuan Deng,1,2 Yue Chen,1,2 Yuye Shi,1,2 Yimin Gan,1,2 Zhikui Deng,1,2 Banghe Ding,1,2 Zhengmei He,1,2 Chunling Wang,1,2 Liang Yu1,2 1Department of Hematology, The Affiliated Huai’an No.1 People’s Hospital of Nanjing Medical University, Huai’an, Jiangsu 223300, People’s Republic of China; 2Key Laboratory of Hematology of Nanjing Medical University, Nanjing 210029, People’s Republic of China*These authors contributed equally to this workCorrespondence: Liang Yu; Chunling Wang 1 Huang River Road West, Huai’an, Jiangsu 223300, People’s Republic of ChinaTel/Fax +86-517 8087 2603Email [email protected]; [email protected]: Retinoic acid receptor gamma (RARG) belongs to the nuclear receptor superfamily and has 90% homology to RAR alpha (RARA) and RAR beta. The promyelocytic leukemia (PML)–RARA fusion gene has been implicated in acute promyelocytic leukemia (APL). RARG gene rearrangement has been identified in a rare subtype of acute myeloid leukemia (AML) that resembles APL. To date, only 10 cases of gene rearrangements involving RARG (nucleoporin [NUP] 98–RARG, promyelocytic leukemia protein–RARG, cleavage and polyadenylation-specific factor 6–RARG, or nucleophosmin [NPM] 1–RARG–NPM1) have been reported. These patients show characteristics similar to APL, including bone marrow morphology, coagulation abnormality, and immunophenotype; however, they are resistant to all-trans retinoic acid and arsenic trioxide treatment. Moreover, there is no optimal therapeutic regimen for this subtype of AML. In this study, we report the clinical presentation and experimental findings of a case of AML with NUP98–RARG gene fusion similar to APL and review other cases of RARG gene rearrangement described in the literature.Keywords: acute myeloid leukemia, acute promyelocytic leukemia, NUP98-RARG, RARG rearrangement

Keywords